Outcome of Children With Metastatic Medulloblastoma Treated With Carboplatin During Craniospinal Radiotherapy: A Children's Oncology Group Phase I/II Study

PURPOSE: We evaluated the feasibility of administering carboplatin as a radiosensitizer during craniospinal radiation therapy (CSRT) to patients with high-risk medulloblastomas (MBs) and supratentorial primitive neuroectodermal tumors, and we report the outcome in the subset with metastatic (M+) MB....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Jakacki, Regina I., Burger, Peter C., Zhou, Tianni, Holmes, Emiko J., Kocak, Mehmet, Onar, Arzu, Goldwein, Joel, Mehta, Minesh, Packer, Roger J., Tarbell, Nancy, Fitz, Charles, Vezina, Gilbert, Hilden, Joanne, Pollack, Ian F.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2012
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4559602/
https://ncbi.nlm.nih.gov/pubmed/22665539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.40.2792
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados